Senior Scientist at Maxion Therapeutics - Cambridge, England, United Kingdom
Chair
Contact Ian Tomlinson
Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.